J. Castilló

发表

Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis

X. Montalban, M. Tintoré, M. Comabella, 2015, Journal of Neuroinflammation.

Circulating EZH2-positive T cells are decreased in multiple sclerosis patients

X. Montalban, J. Río, M. Comabella, 2018, Journal of Neuroinflammation.

MRI phenotypes with high neurodegeneration are associated with peripheral blood B-cell changes.

À. Rovira, X. Montalban, J. Río, 2016, Human molecular genetics.

Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis

X. Montalban, M. Comabella, Nicolás Fissolo, 2014, Journal of Neuroimmunology.

Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis

À. Rovira, X. Montalban, M. Tintoré, 2019, Neurology.

Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis

X. Montalban, M. Tintoré, J. Sastre-Garriga, 2022, Neurology: Neuroimmunology & Neuroinflammation.

TRPM4 mRNA expression levels in peripheral blood mononuclear cells from multiple sclerosis patients

X. Montalban, J. Montaner, M. Comabella, 2013, Journal of Neuroimmunology.

Oral contraceptives do not modify the risk of a second attack and disability accrual in a prospective cohort of women with a clinically isolated syndrome and early multiple sclerosis

À. Rovira, X. Montalban, M. Tintoré, 2021, Multiple sclerosis.

Pregabalin as add-on therapy for refractory partial seizures in every day clinical practice

M. Falip, A. Donaire, I. Maestro, 2007, Seizure.

Progressive presynaptic dopaminergic deterioration in Huntington disease: a [123I]-FP-CIT SPECT two-year follow-up study.

J. Hernández-Vara, J. Castell‐Conesa, J. Gámez, 2014, Clinical nuclear medicine.

Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis

À. Rovira, X. Montalban, M. Tintoré, 2022, JAMA neurology.

COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response

X. Montalban, M. Tintoré, J. Sastre-Garriga, 2020, European journal of neurology.

Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients

X. Montalban, Roland Martin, J. Río, 2014, Autoimmunity.

Menopause does not modify disability trajectories in a longitudinal cohort of women with clinically isolated syndrome and multiple sclerosis followed from disease onset

À. Rovira, X. Montalban, M. Tintoré, 2021, European journal of neurology.

Risk Acceptance in Multiple Sclerosis Patients on Natalizumab Treatment

X. Montalban, M. Tintoré, J. Sastre-Garriga, 2013, PloS one.

Fingolimod for relapsing multiple sclerosis: an update

X. Montalban, A. Horga, J. Castilló, 2010, Expert opinion on pharmacotherapy.

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.

F. Matesanz, J. Lünemann, X. Montalban, 2020, Brain : a journal of neurology.

Tumefactive inflammatory leukoencephalopathy in cocaine users: Report of three cases.

À. Rovira, B. Lhermitte, S. Kremer, 2019, Multiple sclerosis and related disorders.

Should we systematically test patients with clinically isolated syndrome for auto-antibodies?

À. Rovira, X. Montalban, M. Tintoré, 2015, Multiple sclerosis.

Analysis of prognostic factors associated with longitudinally extensive transverse myelitis

À. Rovira, X. Montalban, P. Villoslada, 2013, Multiple sclerosis.

Evaluating the response to glatiramer acetate in relapsing–remitting multiple sclerosis (RRMS) patients

À. Rovira, X. Montalban, M. Tintoré, 2014, Multiple sclerosis.

Does reduced [123I]-FP-CIT binding in Huntington's disease suggest pre-synaptic dopaminergic involvement?

J. Hernández-Vara, J. Castell‐Conesa, J. Gámez, 2010, Clinical Neurology and Neurosurgery.

The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria.

À. Rovira, X. Montalban, M. Tintoré, 2022, Brain : a journal of neurology.

The value of oligoclonal bands in the multiple sclerosis diagnostic criteria

À. Rovira, X. Montalban, M. Tintoré, 2018, Brain : a journal of neurology.

Defining high, medium and low impact prognostic factors for developing multiple sclerosis.

À. Rovira, X. Montalban, M. Tintoré, 2015, Brain : a journal of neurology.

Neurofilament light chain level is a weak risk factor for the development of MS

À. Rovira, X. Montalban, L. Kappos, 2016, Neurology.

The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis centre of Catalonia

À. Rovira, X. Montalban, M. Tintoré, 2021, Multiple sclerosis.

Disability progression markers over 6–12 years in interferon-β-treated multiple sclerosis patients

À. Rovira, X. Montalban, M. Tintoré, 2018, Multiple sclerosis.

Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes

À. Rovira, X. Montalban, M. Tintoré, 2013, Multiple sclerosis.

Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor

Carlos Nos, Xavier Montalban, Manuel Comabella, 2018, Multiple sclerosis.

Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon‐β treatment

X. Montalban, A. Navarro, J. Río, 2013, European journal of neurology.

Deciphering multiple sclerosis disability with deep learning attention maps on clinical MRI

A. Oliver, À. Rovira, X. Montalban, 2023, NeuroImage: Clinical.

Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision

X. Montalban, M. Tintoré, J. Sastre-Garriga, 2012, Multiple sclerosis.

Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre

À. Rovira, X. Montalban, M. Tintoré, 2022, Journal of Neurology.

Optic Nerve Topography in Multiple Sclerosis Diagnosis

À. Rovira, X. Montalban, M. Tintoré, 2020, Neurology.

Optic Nerve Topography in Multiple Sclerosis Diagnosis

À. Rovira, X. Montalban, M. Tintoré, 2020, Neurology.

Simultaneous CMV and Listeria infection following alemtuzumab treatment for multiple sclerosis

X. Montalban, M. Tintoré, J. Sastre-Garriga, 2018, Neurology.

Effect of Changes in MS Diagnostic Criteria Over 25 Years on Time to Treatment and Prognosis in Patients With Clinically Isolated Syndrome

À. Rovira, X. Montalban, M. Tintoré, 2021, Neurology.

Adding brain volume measures into response criteria in multiple sclerosis: the Río-4 score

À. Rovira, X. Montalban, M. Tintoré, 2020, Neuroradiology.

Lesion topographies in multiple sclerosis diagnosis

À. Rovira, X. Montalban, M. Tintoré, 2017, Neurology.

Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis

À. Rovira, X. Montalban, M. Tintoré, 2016, Neurology.

The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS

À. Rovira, X. Montalban, M. Tintoré, 2019, Multiple sclerosis.

Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?

X. Montalban, M. Tintoré, J. Sastre-Garriga, 2022, Multiple sclerosis.

Seizure frequency and social outcome in drug resistant epilepsy patients who do not undergo epilepsy surgery

N. Bargalló, A. Donaire, J. Rumià, 2011, Seizure.

Circulating EZH2-positive T cells are decreased in multiple sclerosis patients

X. Montalban, J. Río, M. Comabella, 2018, Journal of Neuroinflammation.

[Demyelinating lesions as incidental findings in magnetic resonance imaging: a study of 11 cases with clinico-radiological follow-up and a review of the literature].

À. Rovira, X. Montalban, M. Tintoré, 2010, Revista de neurologia.

Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis

X. Montalban, M. Comabella, Á. Vidal-Jordana, 2013, Journal of Neuroimmunology.

Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis: A case report

X. Montalban, M. Tintoré, J. Sastre-Garriga, 2018, Multiple sclerosis.

Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis

X. Montalban, M. Tintoré, M. Comabella, 2015, Journal of Neuroinflammation.

SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis

X. Montalban, M. Comabella, Á. Vidal-Jordana, 2013, Multiple sclerosis.

Plasma exchange for acute attacks of CNS demyelination

X. Montalban, J. Río, L. Ramió-Torrentá, 2009, Neurology.

Brainstem lesions in clinically isolated syndromes

À. Rovira, X. Montalban, M. Tintoré, 2010, Neurology.

Measures in the first year of therapy predict the response to interferon β in MS

J Sastre-Garriga, À. Rovira, X. Montalban, 2009, Multiple sclerosis.

Defining high, medium and low impact prognostic factors for developing multiple sclerosis.

À. Rovira, X. Montalban, M. Tintoré, 2015, Brain : a journal of neurology.

Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response

X. Montalban, M. Tintoré, J. Sastre-Garriga, 2012, European journal of neurology.

Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?

À. Rovira, X. Montalban, M. Tintoré, 2010, Multiple sclerosis.

Deciphering multiple sclerosis disability with deep learning attention maps on clinical MRI

A. Oliver, À. Rovira, X. Montalban, 2023, NeuroImage: Clinical.

Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating Event

À. Rovira, X. Montalban, M. Tintoré, 2023, Neurology.

Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis

À. Rovira, X. Montalban, M. Tintoré, 2016, Neurology.

Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria

A. Toosy, M. Tintoré, J. Sastre-Garriga, 2023, Neurology.

Value of NMO-IgG determination at the time of presentation as CIS

À. Rovira, X. Montalban, M. Tintoré, 2012, Neurology.